NHI Announces Promotion of Kevin Pascoe to Chief Investment Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cantor Fitzgerald Remains Sidelined on National Health Investors (NHI) After Adjusting Estimates
February 21, 2017 6:55 AM ESTCantor Fitzgerald reiterated a Neutral rating and $75.00 price target on National Health Investors (NYSE: NHI) after adjusting estimates. Cantor lowered 2017 normalized FFO estimates to $5.10 (from $5.17) compared with the $5.16 consensus and the $5.06-5.12 guidance. Cantor also initiated a 2018 normalized FFO estimate of $5.30 compared to consensus of... More
